Labshake search
Citations for Tocris :
1 - 50 of 313 citations for Anti PI 4 kinase II beta Antibody since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2021Quote: ... namely the mitogen activated protein kinase kinase (MAPKK) inhibitor U0126 (50 μM) and the CaM kinase II (CaMKII) inhibitor KN-62 (10 μM) (Tocris Bioscience, United Kingdom). The inhibitors were added to the cultures thirty minutes prior to DOI treatment ...
-
bioRxiv - Cell Biology 2021Quote: ... interleukin-1 receptor-associated kinase 1 and 4 (IRAK 1/4; IRAK 1/4 inhibitor, 0.1 μM; Tocris); TANK-binding kinase 1 (TBK1 ...
-
bioRxiv - Cell Biology 2020Quote: ... Rho-kinase inhibitor (Tocris) was added to single cell dissociated organoids ...
-
bioRxiv - Developmental Biology 2021Quote: ... and PI-103 (50 nM; Tocris), which was added for 24 hours ...
-
bioRxiv - Developmental Biology 2021Quote: ... and PI-103 (50 nM; Tocris), which was added for 24 hours ...
-
bioRxiv - Evolutionary Biology 2020Quote: ... and PI-103 (50 nM, Tocris, 2930) in CDM2 to specify APS ...
-
bioRxiv - Molecular Biology 2023Quote: ... and 50 nM PI 103 (Tocris, 2930) and incubated for 24hrs ...
-
bioRxiv - Pharmacology and Toxicology 2022Quote: Kinase inhibitors were purchased from Tocris (www.tocris.com), Selleck Chemicals (www.selleckchem.com) ...
-
bioRxiv - Neuroscience 2022Quote: ... 12-well plates at 3-4 × 105 cells/well in mTeSR1 with 10 µM rho-kinase inhibitor (Y-27632; Tocris, 1254). Medium without the inhibitor was replaced daily until the cells reach 80-100% confluency ...
-
bioRxiv - Cell Biology 2022Quote: The mitogen-activated protein kinase kinase 1/2 (MEK1/2) inhibitor U0126 and the p38 MAPK inhibitor SB203580 were purchased from Tocris Bioscience (Bristol ...
-
bioRxiv - Bioengineering 2022Quote: ... 50 nM PI-103 (Tocris Bioscience, catalogue no. 2930) and 100 ng/ml activin A (Peprotech ...
-
bioRxiv - Immunology 2019Quote: ... inhibitor of PI3-Kinase (Wortmanin, 100 nM, Tocris), inhibitor of p38 MAP kinase (SB203580 ...
-
bioRxiv - Cell Biology 2020Quote: ... and TGF-beta inhibitor A83-01 (100nM, Tocris). The tissue was then agitated for one hour at 37C and the resultant cell suspension was filtered through 100 through 40 μm cell strainers and subjected to ammonium chloride red blood cell lysis ...
-
bioRxiv - Neuroscience 2020Quote: ... 10 µM Dihydro-beta-erythroidine hydrobromide (DHBE, Tocris), which is selective for alpha4-containing nicotinic receptors ...
-
bioRxiv - Immunology 2019Quote: ... inhibitor of p38 MAP kinase (SB203580, 10 μM, Tocris), inhibitor of ERK MAP kinase (PD90859 ...
-
bioRxiv - Immunology 2019Quote: ... inhibitor of ERK MAP kinase (PD90859, 10 μM, Tocris), inhibitor of Cdc42 (ML141 ...
-
bioRxiv - Genetics 2023Quote: ... 10μM Y-27632 Rho-kinase inhibitor (ROCKi; Tocris #1254) was added to culture media ...
-
bioRxiv - Cell Biology 2022Quote: ... 1.5 mM Na3VO4 and 1 µM PI-PLC inhibitor U73122 (Tocris) were added to the homogenization buffer ...
-
bioRxiv - Developmental Biology 2020Quote: ... and 10 μM ALK4/5/7 kinase inhibitor SB431542 (Tocris) at 37 °C in 5% CO2 ...
-
bioRxiv - Cell Biology 2022Quote: ... Stocks of the kinase inhibitor MLi-2 (10 mM; Tocris) were stored in DMSO at −20°C.
-
bioRxiv - Neuroscience 2021Quote: ... coiled-coil containing protein kinase (ROCK1/2) Y27632 (Tocris, Inc.) at 10 µM in PBS for 1-2 hr ...
-
bioRxiv - Cancer Biology 2022Quote: ... 25 μM ML-7 (Tocris, myosin light-chain kinase inhibitor), 500 μM carbenoxolone (Sigma ...
-
bioRxiv - Neuroscience 2022Quote: ... and 10μM Y-27632 dihydrochloride (Rho kinase ROCK inhibitor) (Tocris) from day 20 for the whole duration of terminal differentiation ...
-
bioRxiv - Biophysics 2023Quote: Stocks of the kinase inhibitors MLi-2 (10 mM; Tocris) and GZD-824 (10 mM ...
-
bioRxiv - Neuroscience 2024Quote: ... and 10μM Y-27632 dihydrochloride (Rho kinase ROCK inhibitor) (Tocris) from day 20 for the whole duration of terminal differentiation ...
-
bioRxiv - Bioengineering 2024Quote: ... 10 μM Rho kinase inhibitor (RI, Y-27632) (Tocris, 1254) was used ...
-
bioRxiv - Developmental Biology 2022Quote: ... Media containing Src-kinase inhibitor (10μM PP2; Tocris Bioscience; Cat #1407) and/or FGF8b (100ng/ml ...
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with Rho Kinase Inhibitor (Y-27632, 10 µM, Tocris, 1254) (Day 0) ...
-
bioRxiv - Bioengineering 2022Quote: ... supplemented with Rho Kinase Inhibitor (Y-27632, 10 µM, Tocris, 1254) (day 0) ...
-
bioRxiv - Bioengineering 2023Quote: ... Rho-associated protein kinase (ROCK) (Y-27632, 25 µM, Tocris, UK), or phosphoinositide 3-kinase (PI3K ...
-
bioRxiv - Bioengineering 2023Quote: ... or phosphoinositide 3-kinase (PI3K) (LY 294002, 10 µM, Tocris, UK) for 4 days ...
-
bioRxiv - Developmental Biology 2021Quote: ... the TGF-beta/Activin/Nodal inhibitor SB-431542 (2 μM, Tocris), CHIR99021 (1 μM) ...
-
bioRxiv - Cancer Biology 2022Quote: ... the TGF-beta/Activin/Nodal inhibitor SB-431542 (2 μM, Tocris), CHIR99021 (1 μM ...
-
bioRxiv - Neuroscience 2022Quote: Pharmacological compounds were obtained from the following sources: Rho Kinase Inhibitor (Tocris). Retinoic Acid (Sigma) ...
-
bioRxiv - Developmental Biology 2022Quote: ... 10 μM Rho-associated protein kinase (ROCK) inhibitor Y-27632 (Tocris, 1254) was added to the culture medium for 24 hours.
-
bioRxiv - Bioengineering 2023Quote: ... and TGF-Beta inhibitor (SB431542, Tocris # 1614, 5 μM, days 0-7). Media was changed on days 3 and 6 and then every 2-3 days until day 7 ...
-
bioRxiv - Cancer Biology 2022Quote: ... the TGF-beta/Activin/Nodal inhibitor SB-431542 (2 μM, Cat# 1614, Tocris), CHIR99021 (1 μM ...
-
bioRxiv - Neuroscience 2019Quote: The brain penetrant and orally bioavailable p21-activated kinase (PAK) inhibitor FRAX486 (Tocris, 5190) was used to inhibit PAK1-4 in pharmacological inhibition/rescue experiments ...
-
bioRxiv - Neuroscience 2021Quote: We inhibited LRRK2 kinase activity with the selective LRRK2 inhibitor MLi-2 (Tocris 5756). MLi-2 has low solubility in water ...
-
bioRxiv - Cancer Biology 2023Quote: ... a selection p38 MAP kinase inhibitor and 10 nM nicotinamide (Tocris Bioscience, Bristol, UK) for the first day of passaging to prevent anoikis ...
-
bioRxiv - Genetics 2023Quote: ... When thawing KOLF2.1Js 10 µM Rho-associated protein kinase (ROCK) inhibitor (Y-27632) (Tocris, #1254) was added into the culture media overnight.
-
bioRxiv - Cell Biology 2023Quote: ... The medium was supplemented with 10 μM Rho kinase (ROCK) inhibitor Y-27632 (ROCKi, Tocris) for the first 24 h after passaging.
-
bioRxiv - Bioengineering 2023Quote: ... or pharmacological inhibitors of focal adhesion kinase (FAK) (FAK inhibitor 14, 5 µM, Tocris, UK), Rho-associated protein kinase (ROCK ...
-
bioRxiv - Developmental Biology 2024Quote: ... The medium was supplemented with Rho-associated protein kinase (ROCK) inhibitor Y-27632(Tocris, 1254) at a final concentration of 10 µM for the first 24h after passaging ...
-
bioRxiv - Molecular Biology 2022Quote: ... cells were plated in StemFlex media supplemented with 10uM Y-27632 rho kinase inhibitor (Tocris, 1254). Genomic DNA extraction was performed 72 hours after transfection ...
-
bioRxiv - Neuroscience 2019Quote: ... LY341495 (group II mGluR; Tocris), MK-801 (NMDA receptors ...
-
bioRxiv - Neuroscience 2020Quote: ... angiotensin II (Tocris, Bristol, UK), or human ACE2 (R&D ...
-
bioRxiv - Developmental Biology 2022Quote: 4-Hydroxytamoxifen (4-OHT) (Tocris Bioscience) was dissolved in corn oil (Millipore-Sigma ...
-
bioRxiv - Cell Biology 2021Quote: H9 hESCs were treated with 10 µM Rho-associated protein kinase inhibitor (ROCKi, Tocris Bioscience #Y-27632) for 24 h before they were dissociated to single cells and pelleted ...
-
bioRxiv - Cell Biology 2020Quote: ... The Src-family kinases inhibitor PP2 and Syk inhibitor PRT-060318 were purchased from TOCRIS (Abingdon, UK) and Caltag Medsystems (Buckingham ...